Application

NAUTILUS

Nautilus Biotechnology, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97206701
Filing Date: 01/06/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97206701
MARK INFORMATION
*MARK NAUTILUS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT NAUTILUS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Nautilus Biotechnology, Inc.
*MAILING ADDRESS 2701 Eastlake Ave East, Suite 300
*CITY Seattle
*STATE
(Required for U.S. applicants)
Washington
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
98102
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 001 
*IDENTIFICATION Assays and reagents for use in biologic and medical research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of amino acids, naturally occurring or modified proteins, affinity reagents, enzymes, chemical or nano-particle labels, and chemical buffers, all for the purpose of preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, samples of biological molecules, proteins, proteomes, protein sequence variants and modifications, regulation, translation, and expression in the fields of scientific, diagnostic and clinical research; chemical standards solutions used in DNA, RNA and protein analysis, chemicals used in protein analysis systems; DNA labeling reagents; DNA hybridization buffers solutions
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 005 
*IDENTIFICATION Reagents for medical use; clinical medical reagents; medical diagnostic reagents and assays for testing bodily fluids; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing cells, bodily fluids and tissue for disease detection, monitoring and prognosis
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 009 
*IDENTIFICATION Laboratory equipment, namely, a device for molecular analysis of proteins; laboratory instrument for protein analysis including chemical and biochemical reactions; medical laboratory research instrument for molecular analysis and sequencing including chemical and biochemical reactions; automated laboratory apparatus and computer systems for use in analysis of biomolecules; proteome quantifiers in the nature of proteome analyzers; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and laboratory equipment for making molecular arrays, and parts therefor
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific research; medical research; Protein screening for scientific research purposes; cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical testing for diagnostic or treatment purposes
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Carla B. Oakley
ATTORNEY DOCKET NUMBER 130173-2020
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Morgan, Lewis & Bockius LLP
STREET One Market, Spear Street Tower
CITY San Francisco
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94105
PHONE 415-442-1301
FAX 415-442-1001
EMAIL ADDRESS carla.oakley@morganlewis.com
OTHER APPOINTED ATTORNEY the firm of Morgan, Lewis & Bockius LLP, CARLA B. OAKLEY, SHARON R. SMITH, GENE K. PARK, and JENNA K. STOKES, members of the California Bar, all located at One Market, Spear Street Tower, San Francisco, California 94105, RON N. DREBEN, ANITA B. POLOTT, DANA S. GROSS, CAROLE R. KLEIN, JOSEPH E. WASHINGTON, KRISTIN H. ALTOFF, REBECCA MCDOUGALL, RACHEL FERTIG, JANE W. WISE, KIRAN JASSAL, JONATHAN GOODWILL, MICHELLE RAYNES, CASSANDRA SCIORTINO, CONNIE BOUTSIKARIS, and KRISTEN CANALES, members of the District of Columbia Bar, all located at 1111 Pennsylvania Ave., NW, Washington, D.C. 20004, ANDREW J. GRAY IV and PETER BYRNE, members of the California Bar, located at 1400 Page Mill Road, Palo Alto, California 94304, and RACHELLE A. DUBOW, ERIN CONNORS and AMELIA G. PENNINGTON, members of the Massachusetts Bar, both located at One Federal Street, Boston, Massachusetts 02110
CORRESPONDENCE INFORMATION
NAME Carla B. Oakley
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE carla.oakley@morganlewis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) sftrademarks@morganlewis.com; thomas.loran@morganlewis.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 5
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1750
*TOTAL FEES PAID 1750
SIGNATURE INFORMATION
SIGNATURE /Carla B. Oakley/
SIGNATORY'S NAME Carla B. Oakley
SIGNATORY'S POSITION Attorney of Record, California Bar Member
SIGNATORY'S PHONE NUMBER 415-442-1301
DATE SIGNED 01/06/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97206701
Filing Date: 01/06/2022

To the Commissioner for Trademarks:

MARK: NAUTILUS (Standard Characters, see mark)
The literal element of the mark consists of NAUTILUS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Nautilus Biotechnology, Inc., a corporation of Delaware, having an address of
      2701 Eastlake Ave East, Suite 300
      Seattle, Washington 98102
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 001:  Assays and reagents for use in biologic and medical research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of amino acids, naturally occurring or modified proteins, affinity reagents, enzymes, chemical or nano-particle labels, and chemical buffers, all for the purpose of preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, samples of biological molecules, proteins, proteomes, protein sequence variants and modifications, regulation, translation, and expression in the fields of scientific, diagnostic and clinical research; chemical standards solutions used in DNA, RNA and protein analysis, chemicals used in protein analysis systems; DNA labeling reagents; DNA hybridization buffers solutions
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 005:  Reagents for medical use; clinical medical reagents; medical diagnostic reagents and assays for testing bodily fluids; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing cells, bodily fluids and tissue for disease detection, monitoring and prognosis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 009:  Laboratory equipment, namely, a device for molecular analysis of proteins; laboratory instrument for protein analysis including chemical and biochemical reactions; medical laboratory research instrument for molecular analysis and sequencing including chemical and biochemical reactions; automated laboratory apparatus and computer systems for use in analysis of biomolecules; proteome quantifiers in the nature of proteome analyzers; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and laboratory equipment for making molecular arrays, and parts therefor
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific research; medical research; Protein screening for scientific research purposes; cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical testing for diagnostic or treatment purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Carla B. Oakley. Other appointed attorneys are the firm of Morgan, Lewis & Bockius LLP, CARLA B. OAKLEY, SHARON R. SMITH, GENE K. PARK, and JENNA K. STOKES, members of the California Bar, all located at One Market, Spear Street Tower, San Francisco, California 94105, RON N. DREBEN, ANITA B. POLOTT, DANA S. GROSS, CAROLE R. KLEIN, JOSEPH E. WASHINGTON, KRISTIN H. ALTOFF, REBECCA MCDOUGALL, RACHEL FERTIG, JANE W. WISE, KIRAN JASSAL, JONATHAN GOODWILL, MICHELLE RAYNES, CASSANDRA SCIORTINO, CONNIE BOUTSIKARIS, and KRISTEN CANALES, members of the District of Columbia Bar, all located at 1111 Pennsylvania Ave., NW, Washington, D.C. 20004, ANDREW J. GRAY IV and PETER BYRNE, members of the California Bar, located at 1400 Page Mill Road, Palo Alto, California 94304, and RACHELLE A. DUBOW, ERIN CONNORS and AMELIA G. PENNINGTON, members of the Massachusetts Bar, both located at One Federal Street, Boston, Massachusetts 02110. Carla B. Oakley of Morgan, Lewis & Bockius LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      One Market, Spear Street Tower
      San Francisco, California 94105
      United States
      415-442-1301(phone)
      415-442-1001(fax)
      carla.oakley@morganlewis.com
The docket/reference number is 130173-2020.
Carla B. Oakley submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Carla B. Oakley
       PRIMARY EMAIL FOR CORRESPONDENCE: carla.oakley@morganlewis.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sftrademarks@morganlewis.com; thomas.loran@morganlewis.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1750 has been submitted with the application, representing payment for 5 class(es).

Declaration

Declaration Signature

Signature: /Carla B. Oakley/   Date: 01/06/2022
Signatory's Name: Carla B. Oakley
Signatory's Position: Attorney of Record, California Bar Member
Signatory's Phone Number: 415-442-1301
Signature method: Sent to third party for signature
Payment Sale Number: 97206701
Payment Accounting Date: 01/06/2022

Serial Number: 97206701
Internet Transmission Date: Thu Jan 06 21:03:58 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202201062103586
80613-97206701-81076bb55c750332e1b7bbe17
52388a0974aa8543a717232413f523a87e73f19-
DA-03582575-20220106201308307848

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed